Duovir N Tablet

Duovir N Tablet cause multiple side effects like any other chemical based medication. Side effects may range from mild to extreme. Any persistent, worsening, or unusual symptoms should be immediately reported to the doctor.
● Dizziness
● Headache
● Nausea
● Vomiting
● Fatigue
● Weakness
● Cough
● Skin Rashes
● Congestion
● Muscle or Joint Pain
● Low Phosphate in Blood
● Severe Allergic Reactions
● Extreme Mood Changes such as Depression, Anxiety, Suicidal thoughts etc.
● Liver Problems
● Liver Damage
● Kidney Problems
● Lactic Acidosis
● Blood Problems
● Low Bone Density

Duovir N Tablet is taken orally. Tablet is swallowed as it is with the help of water. It can be taken after or before food consumption. Although taking it on an empty stomach or at bedtime is often recommended to reduce side effects. Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy. In general, Duovir N Tablet dosage is one tablet twice daily at the same time every day. For more personalized assistance and exact dosage, talk to your doctor about the same.

Duovir N Tablet contains lamivudine, zidovudine (NRTIs), and nevirapine (NNRTI), inhibits HIV reverse transcriptase, aids CD4 immune cell production to prevent viral replication and reduce viral load.It also delays AIDS progression.

• Anderson, P. L., & Rower, J. E. (2010). Zidovudine and lamivudine for HIV infection. Clinical medicine reviews in therapeutics, 2, a2004.
• Wang, Y., De Clercq, E., & Li, G. (2019). Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert opinion on drug metabolism & toxicology, 15(10), 813-829.
• Yoshida, Y., Honma, M., Kimura, Y., & Abe, H. (2021). Structure, synthesis and inhibition mechanism of nucleoside analogues as HIV‐1 reverse transcriptase inhibitors (NRTIs). ChemMedChem, 16(5), 743-766.
• Esser, S., Helbig, D., Hillen, U., Dissemond, J., & Grabbe, S. (2007). Side effects of HIV therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 5(9), 745-754.